OMNIAB, INC. Cash Equivalents, at Carrying Value
OMNIAB, INC. (OABI) had Cash Equivalents, at Carrying Value of $19.50 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-08-06
- 2026-06-30: Cash Equivalents, at Carrying Value $19.50M.
- 2026-03-31: Cash Equivalents, at Carrying Value $22.94M.
- 2025-12-31: Cash Equivalents, at Carrying Value $20.08M.
- 2024-12-31: Cash Equivalents, at Carrying Value $17.62M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $19.50M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $22.94M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $20.08M 10-Q · filed 2026-08-06 |
| 2024-12-31 | $17.62M 10-K · filed 2026-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |